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ABSTRACT
Schiff bases were obtained by condensation of 2-amino-l,3,4-thiadiazole with 5-substimted-salieylaldehydes
which were further used to obtain complexes of the type [M(L)]CIz, where M=Co(II), Cu(II), Ni(II) or Zn(II).
The new compounds described here have been characterized by physical, sIxtral and analytical data, and have
been screened for antibacterial activity against several bacterial strains such as Escherichia coli, Staphylococcus
aureus, and Pseudomonas aeruginosa. The antibacterial potency of these Schiff bases increased upon
ehelation/complexation, against the tested bacterial sixties, opening new aproaches in the fight against
antibiotic resistant strains.
INTRODUCTION
Many studies stressed the role of metal ions in important biological processes, whereas the inorganic
pharmacology started to be an important field per se .with more than 25 inorganic compounds, being used in
therapy as antibacterial, antiviral and antieaneer drugs’’. Kirsebmer et al have suggested* that the transfer of the
metal ion from the ligand to the cancer-associated viruses was an important mechanism for designing new
anticancer therapies. The inverse process, i.e., coordinating a metal ion from an important biomolecule, such as
for instance a zinc finger protein, has recently been used to design novel antiviral therapies, targeted against
human immunodeficiency (HIV) and human papilloma virus (HPV’)ilffeetions.
9 Palladium and platinum
complexes of 6-mercaptopurine have already been shown to destroy
0 the adenoearcinomas, whereas the
complexes of dialkyldithiophosphate, cisplatin and carboplatin are potent antineoplastic drugs used in
chemotherapy2. They show their best results in the treatment of testicular and ovarian carcinoma and are also
effective against bladder tumors and tumors of head and neck.
12 It has also been demonstrated that
chelation/complexation tend to make biologically inactive compounds active3q6. All these evidences however,
need to highlight more th,%b,ioologieal application of qhe.,lation in the.ate,utic potentials. For.sthis purpose, keeping
in view the antibacterial’’’’, antiviral’, antiftmgal"-’’, antiturnoF and antileukemia properties of some
thiadiazole derivatives, we report here some new Sehfff bases, obtained by the condensation reaction of 2-
3 ammo-1,3,4-thiadiazole with 5-substituted salieyloaldehydes (I -HL ) (Fig. 1). These newly prepared Schiff
bases were used to synthesize their Co(II), Cu(II), Ni(II) and Zn(II) complexes. In order to evaluate and
establish the role of metal ions on the antibacterial activity, these Schiff bases in comparison to their metal(II)
complexes were screened for antibacterial activity against bacterial species such as Escherichia coB,
Staphylococcus aureus, and Pseudomonas aeruginosa, all of which ultimately developed increasing resistance
to the classical antibiotics.
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HL2=R=Br N-’-N HO
HL3=R--OCH 3
Fig. 1. Structure of the Schiff bases
EXPERIMENTAL
Material and Methods
All chemicals and solvents used were of Analar grade. All metal salts were used as chlorides. IR spectra were
recorded on a Philips Analytical PU 9800 FTIR spectrophotometer as KBr discs. UV-Visible spectra were
obtained in DMF on a Hitachi U-2000 double-beam spectrophotometer. C, H and N analyses was carried out by
Butterworth Laboratories Ltd. Conductance of the metal complexes was determined in DMF on a Hitachi YSI-
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32 model conductometer. Magnetic measurements were made on solid complexes using the Gouy method.
Melting points were recorded on a Gallenkamp apparatus and are uncorrected.
Preparation of Schiff base OtL)
Salicylaldehyde (1.2 g, 1.1 mL, 0.01 M) in ethanol (10 mL) was added to a hot ethanol solution (20 mL) of 2-
amino- 1,3,4-thiadiazole (1.0 g, 0.01 M). Then 2-3 drops of conc.H:SO4 were added and mixture refluxed for 2
h. On cooling, a yellow solid product was formed which was filtered, washed with ethanol, then with ether and
dried. Crystallization in hot ethanol gave HL (1.0g, 80 ,%), M.p 134C. The same method was applied for the
preparation of HL (1.5 g, 70 %), M.p 115C and HL (1.6 g, 65 %), M.p 128C by using their respective
reagents in the same molar ratio.
Preparation ofcobalt(H) Complex ofHL
A warm ethanol solution (20 mL) ofHL (0.6 g, 0.002 M) was added to a magnetically stirred solution of cobalt
chloride hexahydrate (0.24 g, 0.001 M) in distilled water (25 mL). The mixture was refluxed for h and cooled
to room temperature. On cooling, pink precipitates were formed which were filtered, washed with ethanol,
acetone and ether, and dried by suction. Crystallization in aqueous ethanol (70 30) gave the desired metal
complex (1) (0.5 g, 68 %). All other metal complexes were formed respectively following the same method.
Antibacterial Studies
The synthesized metal complexes, in comparison to the uncomplexed Schiff bases were screened for their
antibacterial activity against pathogenic bacterial species, Escherichia coli, Staphylococcus aureus and
Pseudomonas aeruginosa. The paper disc diffusion method
6"2 was adopted for the determination of
antibacterial activity.
RESULTS AND DISCUSSION
Physical Properties
The Schiff bases (HL-HL3) (Fig. 1) were prepared by refluxing an appropriate amount of 2-amino-l,3,4-
thiadiazole with the respective salicylaldehydes in ethanol in molar ratio. The structures of these Schiff
bases were established with the help of their IR, NMR, and microanalytieal data (Tables and 2). All metal
complexes [(1)-(16)] (Table 3) of these Sehiff bases were air stable and prepared by the stoichiometric reaction
of the respective metals chlorides with the Schiff base in molar ratio M:L of 1:2. The complexes are intensely
colored and amorphous solids, which decompose above 200 C. They are insoluble in common organic solvents
such as ethanol, methanol, chloroform or acetone being only soluble in DMSO and DMF. Molar conductance
values of the soluble complexes in DMF show low values (14-22 ohm4cm2mol") indicating
29 that they are all
non-electrolytic in nature.
Table I. Spectral and Analy_tica Data ofthe Schiff bases
Schiffbase IR (cm") HNMR
CgH7N3OS
[2o5.]
CgH6BrN3OS
[284.0]
C10H9N302S
[235.1]
1630 (s, HC=N),
]620 (s, C=N).
3430 (br, OH),
1635(s, HC=N),
1620 (s, C=N).
3432 (br, OH),
1635 (s, HC=N),
1625 (s, C=N).
(DMSO-d) ppm
8.7 (s, 1H, heteroarom-
atic), 7.4 (s, 1H,
CH=N), 6.8 (m, IH,
Ph), 7.2 (m, H, Ph),
7.4 (m, 1H, Ph), 7.7 (m,
1H, Ph), 9.9 (s, 1H,
.0),
8.7 (s, 1H, heteroarom-
atic), 7.5 (s,IH,CH=N),
7.3 (m, IH, Ph), 7.6 (m,
1H, Ph), 7.8 (m, IH,
Ph), 10. (s, 1H, OH).
3.6 (s, 3H, OCH3, 8.8
(s, 1H, heteroaromatic),
7.6 (s, 1H, CH=N), 7.4
(m, 1H, Ph), 7.6 (m,
1H, Ph), 7.8 (m, IH,
__Ph ,_.2 (s, H, 0H):
C NMR
(DMSO-d) 0)pm)
116.4, 118.2, 118.5
(aromatic), 131.1,
132.2, 160.5 (aromatic),
143.1,156.1
(heteroaromatic), 165.2
(HC=N).
116.5, 118.1, 118.6
(aromatic), 131.5,
132.3, 160.5 (aromatic),
143.3, 155.8
(heteroaromatic), 165.2
.(I-IC=N).
31.7 (OCH3), 116.5,
118.2, 118.6 (aromatic),
131.7, 132.1,160.5
(aromatic), 143.2,
156.3 (heteroaromatic),
!65.! (HC=N).
Calc (Found)%
.,(2, H ,N
52.7 3.4 20.5
(52.9) (3.2) (20.8)
38.0 2.1 14.8
(38.4) (2.0) (14.5)
51.0 3.8 17.9
(51.3) (3.9) (17.6)
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Table 2. and Data of the Metal
No Metal chelate/ Yield M.p (C)
Mol. Formula (.%). (deeomp)
"i [Co(L).]C1_"[537.’9] 60 222-224
C, j-I,CoCIN.OS
2 [C6(L)]C12 [697] 56 220-222
C, j-I,.CoC12Br2N.OS
3 [Cb(L’)2]C12 [597.-9]- 58 221-223
B.M. Cale (Found)%
(ff), C H N
4.2 40.2 2.2 1516
(40.6) (2.1) (15.4)
4.7 31:0-1.4 12.1
(3!.... 3) (1:4).(.12.3)
4.5 40.1 2.7 14.0
C,,J-I,,CoC12N,O,S, (40,5) (2.8) (14.2)
4 [Cfi(L)]C12 [5"4215] 6i 225-227 1’13’ 39.9 2.2 15.5
CsH2CuC12NO2S., (40.2) (2.3) (15.2)
5 [Cu(LZ)]C12 [700.3] 57 218-220 1.6 30.8 1.4 12.0
ClsHoCuC12Br2N,:CaSa (30.5) (1.0) (12.3)
6 [Cu(L )’2]C12 [602.-51’ 58 218-220 1.4 39.8 2.7 13.9
C,H,,:(:uCI2N,O,Sa (39.6) (2.9) (13.4)
7 [Ni(L’r)i,](l"[537.] 58 2i’222 3’i 40.2 .2"’1516
C,-I, IiC12N,OS (40.6) (2.5) (15.4)
8 [Ni(L]C12 [695.5] 60 226-28 .4 31.1 ’’r.’4 12.1
C,d-I,,NiC12Br2N60.S (31,0) .(1.6) (.1.2.3)
9 [Ni(L")2]CI’2 [59"].7]’ 61 220-222 3’. 40.2 2.7 14.1
CI,.NiCI2N.OS (40.5) (2.4) (14,0)
[Zh(L)_]C121544.4] 56 215-218 ’Dia 39.7 1.8 15.4
C, d-I,ZnClzN,OS ..................................... (39.2)(1.7) (15.9)
11 [Zh0L-)9]C12 [7022] 58 222-224 Dia 30.1 1.4 12.0
C,I,,Z’nCI2Br2N,OSa (30.5) (1.9) (12.1)
12 [Zh(I’)2]C12 [604.-4] 60 2’18-220’ Dia 39.7 2.6 13.9
CoI,,ZnC12NaO,S. (39.5). (2.3) (!3..6)
Table 3. IR and UV-Visible Spectral Data of the Metal(l[)Chelates ,No’,’ .’ .’. ’,’,..". ’.,’ ,’], ._’ !R(em,’ ) .’,’",:" ’.,. ". ’Lma (cm-i).
1625 (HC N), 1600 (C N), 30210, 18425, 8815
525 (M-N), 455 (M-O)
2 1620 (HC N), 1595 (C N), 30575, 17850, 8665
5..25. (M-N):..4.5.5 (M-0)
3 1620 (HC N), 1600 (C N), 30545, 17950, 8810
530 .QCI,N):..460 (M-O)
4 1620 (HC N), 1600 (C N), 30550, 22152
530...(M-N),. 460.(M,O)
5 1625 (HC N), 1600 (C N), 30645, 22355
5,25-,, ,469,-o) :6 1620 (HC N), 1595 (C N), 30575, 22315
53o,-,N), ass f,0)
7 1625 (HC N), 1600 (C N), 28540, 15945, 10145
5,,25 ,,, 4,,60,0)
8 1625 (HC N), 1600 (C N), 29210, 16250, 9815
10
530 -N),,455
"1620 (HC N),’1595 (C"= N),
525 (M-N’), 455 (Mr0)
162o(c
5.25 (M-N), 460..-O)
1625 (HC , 10 (C N),
525-,4 -O)
620 (HC , 1595 (C N),
525-, 45,5 -O)
28880, 16175, 9910’
28450
28475
28510
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Infrared spectra
IR spectra of the Schiff bases showed the absence of bands at 1735 and 3420 cm
"1 due to c_a-bonyl v(C=O) and
v(NH2) stretching vibrations and, instead, appearance of a strong new band at --1635 era- assigned
3 to the
azomethine v(HC=N) linkage. The comparison of the infrared tra of the Schiff bases with their metal
chelates indicated that the Schiff bases were principally coordinated to the metal atom in three ways, thus
representing the ligands as acting tridcntatc.ly:
a) The band .appearing at 1635 cm" duc to the azomethine, shifted to lower frequency by -10-15 cm"
indicating
31 participation of the azomethine nitrogen in complexation.
b) The band at 1620 assigned to thiadiazole ring v(C=N) nitrogen also shifted to lower frequency by -10
cm-I which was indicative of the involvement of thiadiazole ring nitrogen in chelation.
c) A band appearing at 3425 em" assigned to v(OH) in the Sehiff base compounds was not found in the
spectra of their metal complexes indicating dcprotonation and coordination of the hydroxyl oxygen to
the metal ion.
d) Further evidence of the coordination of these Schiff base compounds with the metal ions, was shown
by the appearance of weak low frequency new bands at 525-530 and 455-460 em (Table 3). These
were, assigned
2 to the metal-nitrogen v(M-N) and metal-oxygen v0Vl-O) respectively. These new
bands were observable only in the Slctra of the metal complexes and not in the spectra of its
uncomplcxcd Sehiff base compounds thus confnaning participation of these hetero groups (O or N) in
the coordination.
NMR Spectra
The NMR spectral data of Schiff bases as well as some of their Zn(II) complexes taken in DMSO-ds arc listed in
Tables and 4. The Schiff bases exhibited signals duc to all the expected protons in their expected region and
have bccn identified from the integration curves found to bc equivalent to the total nurnbcr of protons deduced
from their proposed structures. These were compared with the reportexP
3 signals of the known identical
compounds and give further support for the compositions of these new Schiff bases as well as their complexes
suggested by their IR and elemental analyses data. Comparison of the chemical shifts of the uncomplcxcd Schiff
bases with those of the corresponding complexes show that some of the resonances arc shifted upon
complcxation. In each case, the protons assigned duc to hcteroaromatic (HC=N), azomcthinc (HC=N), hydroxyl
group (OH) and substituted aromatic were found at around 6 8.8, 7.4, 9.9 and 6.8-7.7 ppm in the spectra of the
Schiff bases. The protons duc to heteroaromatic, azomethine and substituted aromalac undergo shift towards
downficld in the complexes indicating coordination of these groups with the metal atom. Also, protons duc to
hydroxyl oup (OH) were found absent in the spectra of the complexes. The absence of these signals
suggested the deprotonation of the hydroxyl oxygen atom of the Schiff base on complcxation. The same shifts
were observed in the 3C NMR spectral data of the Sehiff bases and their complexes.
Table 4: NMR spectra of the Zn(II) complexes 10-12.
Cbmplex I.HNMR (DMS0-d6) (Ppm) .’.’c NMR (DMSO-d6) (ppm)
10 8.8 (s, 1H, heteroaromatic), 7.5 (s, 1H, 116.6, 118.3, 118.7 (aromatic), 131.2,
11
CH=N), 6.8 (m, 1H, Ph), 7.2 (m, 1H,
.Ph), 7:4 (m, 1H: Ph), 7.7 (m, 1H, Ph).
8.9 (s, 1H, heteroaromatic), 7.7 (s, 1H,
CH=N), 7.3 (m, 1H, Ph), 7.6 (m, 1H,
Ph), 7.8.(m, !.H, Ph)...
3.6 (s, 3H, OCH3, 8.9 (s, 1H,
heteroaro-matic), 7.8 (s, 1H, CH=N),
7.6 (m, 1H, Ph), 7.5 (m, IH, Ph), 7.7
(m, !H, Ph).
132.3, 160.7 (aromatic), 143.3, 156.4
(heeroaromafic), 165.3(HC=N).
116.7, 118.3, 118.8 (aromatic), 131.7,
132.5, 160.7 (aromatic), 143.4, 155.9
(heteroaromatic), 165.3 (HC=N).
31.8 (OCH3), 116.7, 118.2, 118.7
(aromatic), 131.7, 132.3, 160.7
(aromatic), 143.4, 156.3
(heteroaromatic), 165.3 (HC=N).
Magnetic Moments and UV-Visible Spectra
The room temperature magnetic moment of the solid cobalt(II) complexes was found lie in the range (4.2-4.7
35 B.M), indicative of three unpaired electrons per Co01) ion in an octahedral environment. The Cu(II)
complexes showed Xeff values in the range (1.4-1.6 B.M) indicative of one unpaired electron per Cu(II) ion
suggesting
36 these complexes within the range consistent to spin-free distorted octahedral geometry. Similarly
the Ni(II) complexes showed xefr values in the range (3.1-3.4 B.M), corresponding
36 to two unpaired electrons
per Ni(II) ion for their ideal six-coordinated configuration. The Zn(II) complexes were all found diamagnetic.
The electronic sp,ectra of the Co01) chelates sowed ree bartds obsqrved at 878(]-8815, 417560-18425 and
30210-30575 cm" which may, be assigned to -’Tg "T_g(F), ’T,s ----A,(F) and "T,s Ts(P) transitions
respectively and are suggestive37’38 of the octahedral geometry around the colSalt ions.
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The Cu(II) comolexes showed three
2 absotion bands tmtween 10 Dq band for a distorted octedral gometry
correspondinga’ to the transitions E T2. The bands at 22152-22355 and 30550-30545 cm" may be due to
intra-ligand charge transfer transitions.
The Ni(II) complexes exhibited three spin-allowed bands at }815-10145, .15945-1625 and 28540-2920 em"l
assignable4’42 respectively, to the transitions A(F) ---T2(F)(v), AfF) --
T(F)(2) and AfF)
-""Tgg(P)(v3) which were characteristic oftheir octah&]ral geometry (Fig 2).
The diamagnetic zinc(II) complexes did not show any d-d bands and their spectra are dominated only by charge
transfer bands. The charge transfer band at 28450-28510 cm
q was assigned
43 due to transition 2Es 2T2s
possibly in an octahedral environment. R
M=Co(II), Cu(II), Ni(II) or Zn(II) R
(Fig. 2) Proposed Structure of the Metal(II) Complex
Antibacterial Properties
The title Sehiff bases and their metal chelates were evaluated for their antibacterial activity against bacterial
strains of Escherichia cob (a), Staphylococcus aureus (b) and Pseudomonas aeruginosa (c) (Table III). The
compounds were tested at a concentration of 30 g/0.01 mL in DMF solution using the paper disc diffusion
method. The diameter of the susceptibility zones were measured in (ram). The results of which are shown in
Table 4. The susceptibility zones measured were the clear zones around the discs killing the bacteria.
All the Schiffbases and their complexes individually exhibited varying degrees of inhibitory effects on the
growth of the tested bacterial species. The antibacterial results evidently show that the activity of the Sehiffbase
compounds became more pronounced when coordinated to the metal ions.
On the basis of these observations, it is claimed that chelation dominantly affects the biological behavior of the
compounds that are potent against some bacterial strains. It is however, suspected that factors such as solubility,
dipole moment and cell permeability mechanisms are certainly influenced by the presence of the metal ions.
Table III. Antibacterial Activity Data of the Schiff bases and its Metal(II) chelates
’i"l
b ial
:a- Escheriha Co i, b Staphylococcus aureus, c Paeudomonas aeruginosa
o o Inhibition zone diametermm (A inhibition): +, 6-10 (27-45 %); ++, 10-14
(45-64 %); +++, 14-18 (64-82 %); :, 18-22 (82-100 %). Percent inhibition values are relative
to inhibition zone (22 mm) ofthe most active compound wtth 100% inhibition.
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